Euroapi S.A. (EPA: EAPI)

Market Cap	267.69M
Revenue (ttm)	971.30M
Net Income (ttm)	-287.30M
Shares Out	95.26M
EPS (ttm)	-3.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	159,428
Open	2.750
Previous Close	2.800
Day's Range	2.732 - 2.836
52-Week Range	2.260 - 7.020
Beta	0.56
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 11, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 3,329
• Stock Exchange: Euronext Paris
• Ticker Symbol: EAPI

Financial Performance

In 2023, Euroapi's revenue was 1.02 billion, an increase of 3.87% compared to the previous year's 980.90 million. Losses were -189.70 million, 1164.7% more than in 2022.